355 results on '"Rump, L. C."'
Search Results
2. Kurzfassung der S2k-Leitlinie Erkrankungen der Nierenarterie
3. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up
4. A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program
5. Effekte einer Salzsubstitution
6. Nachruf auf Prof. Dr. Bernd Grabensee: 23.07.1939–14.05.2017
7. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up
8. Effects of salt substitution
9. Prevalence of Malignancies in Patients With Primary Aldosteronism
10. Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption
11. Renal artery revascularization after unsuccessful percutaneous therapy: a single centre experience
12. Office and ambulatory pulse pressure—association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)
13. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension
14. Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
15. Careful clinical monitoring in comparison to sequential Doppler sonography for the detection of acute rejection in the early phase after renal transplantation
16. Chronic treatment with angiotensin-(1–7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice
17. Nephrogene sytemische Fibrose - 10 Fälle der Bochumer Klinik: FFP3
18. Role of the renin-angiotensin system in autoimmune inflammation of the CNS: targeting the angiotensin II receptor as a new therapeutic option in multiple sclerosis?: SC112
19. Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Connʼs Registry
20. Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension
21. α2A-Adrenoceptors Regulate Sympathetic Transmitter Release in Mice Kidneys
22. Effects of imidazolines on noradrenaline release in rat isolated kidney
23. Methoxamine inhibits noradrenaline release through activation of α1- and α2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins
24. Weight loss with purpura and pain at the distal femora
25. Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney
26. Activation of β2-adrenoceptors by isoprenaline and adrenaline enhances noradrenaline release in cortical kidney slices of young spontaneously hypertensive rats
27. Contractile effects of tacrolimus in human and rat isolated renal arteries
28. Dopamine receptor modulation of noradrenaline release by carmoxirole in human cortical kidney slices
29. Stellenwert der Aldosteronantagonisten: Wenn die Dreierkombination den Blutdruck nicht ausreichend senkt
30. DOAC use in patients with chronic kidney disease
31. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up
32. Erratum to: Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
33. Mass Spectrometry–Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism
34. Modulation der renalen Transmitter-Freisetzung durch präsynaptische Rezeptoren
35. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up
36. PREVENTION OF MICROALBUMINURIA: PREDICTORS FOR A GOOD RESPONSE TO OLMESARTAN TREATMENT (ROADMAP TRIAL)
37. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol
38. Ambulatory blood pressure changes and predictors of response in patients undergoing renal sympathetic denervation
39. Renal sympathetic denervation increases urinary sodium excretion in patients with treatment resistant hypertension
40. Clinical nephrology - miscellaneous
41. Evaluation of a Recently Established Test for Familial Hyperaldosteronism Type 1.
42. Primary and secondary glomerulonephritis II
43. Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients
44. Renal artery revascularization after unsuccessful percutaneous therapy: a single centre experience
45. CELL-SPECIFIC DELETION OF THE TYPE 1A (AT1A) ANGIOTENSIN RECEPTOR FROM COLLECTING DUCT EXAGGERATES ANGIOTENSIN II- DEPENDENT HYPERTENSION
46. Pathophysiology and clinical studies in CKD 1-5.
47. MOLECULAR MECHANISM FOR ANGIOTENSIN II INDUCED PROTEINURIA
48. OLMESARTAN/HYDROCHLOROTHIAZIDE COMBINATION THERAPY IMPROVES HYPERTENSION GRADE CLASSIFICATION IN UNCONTROLLED HYPERTENSION
49. Experimental pathology
50. CILIARY NEUROTROPHIC FACTOR PLAYS AN IMPORTANT ROLE IN AGE-DEPENDENT VASCULAR FUNCTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.